Bide Pharmatech Co. Ltd. A Capital Reinvestment Ratio
Bide Pharmatech Co. Ltd. A capital reinvestment ratio. Bide Pharmatech Co. Ltd. A (688073) has a Capital Reinvestment Ratio of 0.86x as of December 2025, meaning it reinvests 1% of its operating cash flow (CN¥28.32 Million) in capital expenditures (CN¥24.28 Million). See Bide Pharmatech Co. Ltd. A (688073) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Bide Pharmatech Co. Ltd. A (2020–2025)
Capital reinvestment ratio of Bide Pharmatech Co. Ltd. A from 2020 to 2025. This chart tracks Bide Pharmatech Co. Ltd. A's Capital Reinvestment Ratio across 4 annual periods. See Bide Pharmatech Co. Ltd. A free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
Bide Pharmatech Co. Ltd. A Capital Reinvestment Ratio by Year (2020–2025)
Bide Pharmatech Co. Ltd. A capital reinvestment ratio by year from 2020 to 2025. For the full cash flow conversion analysis, see how efficiently does Bide Pharmatech Co. Ltd. A generate cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.86x | CN¥28.32 Million | CN¥24.28 Million | ▲ +53.6% |
| 2024 | 0.56x | CN¥158.31 Million | CN¥88.35 Million | ▼ -56.6% |
| 2022 | 1.29x | CN¥29.87 Million | CN¥38.41 Million | ▼ -87.6% |
| 2020 | 10.35x | CN¥3.65 Million | CN¥37.73 Million | — |